Tianjin Ringpu Bio-Technology Co.,Ltd. (SHE:300119)
China flag China · Delayed Price · Currency is CNY
19.16
+0.12 (0.63%)
Feb 3, 2026, 3:04 PM CST

SHE:300119 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
3,3473,0452,6842,0631,9871,984
Other Revenue
25.3325.3324.9821.4420.2316.09
3,3733,0702,7092,0842,0072,000
Revenue Growth (YoY)
0.27%13.32%29.98%3.84%0.34%36.40%
Cost of Revenue
1,9901,8201,5271,075969.26920.78
Gross Profit
1,3831,2501,1821,0101,0381,080
Selling, General & Admin
696.52640.33584.43486.89529.17521.48
Research & Development
217.9196.04172.47132.1116.64110.96
Other Operating Expenses
26.1521.8920.0420.418.9718.44
Operating Expenses
957.88874.82803.78659.1682.72680.24
Operating Income
424.79375.04378.65350.43355.16399.38
Interest Expense
-35.65-31.21-25.42-28.43-23.82-27.17
Interest & Investment Income
70.4914.1120.8115.2524.274.88
Currency Exchange Gain (Loss)
0.780.780.510.41-0.28-1.21
Other Non Operating Income (Expenses)
-5.13-4.63-6.120.43-3.21-1.25
EBT Excluding Unusual Items
455.27354.08368.42338.1352.12374.63
Gain (Loss) on Sale of Investments
10.29-10.7161.2651.38113.8116.75
Gain (Loss) on Sale of Assets
3.74-0.02114.09-0.010.1-0.02
Asset Writedown
-0.15-0.14-0.47-0.11-9.1-1.34
Other Unusual Items
25.0725.0727.8922.1630.8820.9
Pretax Income
494.21368.29571.19413.81487.79510.92
Income Tax Expense
49.4538.4656.1840.0454.271.43
Earnings From Continuing Operations
444.77329.83515373.77433.59439.49
Minority Interest in Earnings
-30.5-29.11-61.41-27.07-20.81-41.29
Net Income
414.26300.72453.59346.7412.78398.2
Net Income to Common
414.26300.72453.59346.7412.78398.2
Net Income Growth
-3.36%-33.70%30.83%-16.01%3.66%104.88%
Shares Outstanding (Basic)
456460464463402396
Shares Outstanding (Diluted)
456460464463402396
Shares Change (YoY)
-1.15%-0.69%0.11%15.06%1.61%-0.28%
EPS (Basic)
0.910.650.980.751.031.01
EPS (Diluted)
0.910.650.980.751.031.01
EPS Growth
-2.23%-33.24%30.69%-27.00%2.02%105.46%
Free Cash Flow
412.03550.21158.4717.0576.75129.27
Free Cash Flow Per Share
0.901.200.340.040.190.33
Dividend Per Share
0.3000.3000.4000.3000.3500.400
Dividend Growth
-25.00%-25.00%33.33%-14.29%-12.50%60.00%
Gross Margin
41.00%40.71%43.65%48.44%51.71%53.97%
Operating Margin
12.60%12.22%13.98%16.81%17.70%19.96%
Profit Margin
12.28%9.80%16.74%16.63%20.57%19.91%
Free Cash Flow Margin
12.22%17.92%5.85%0.82%3.82%6.46%
EBITDA
657.41567.43517.4457.89439.13495.13
EBITDA Margin
19.49%18.48%19.10%21.97%21.88%24.75%
D&A For EBITDA
232.62192.39138.76107.4583.9795.75
EBIT
424.79375.04378.65350.43355.16399.38
EBIT Margin
12.60%12.22%13.98%16.81%17.70%19.96%
Effective Tax Rate
10.01%10.44%9.84%9.68%11.11%13.98%
Revenue as Reported
3,3733,0702,7092,0842,0072,000
Advertising Expenses
-13.047.446.647.726.51
Source: S&P Global Market Intelligence. Standard template. Financial Sources.